Pyrrolopyrimidines: Novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models

Journal of Pharmacology and Experimental Therapeutics

Volumn 281, Issue 2, 1997, Pages 895-904

  Hall, E D ^a   Andrus, P K ^a   Smith, S L ^a   Fleck, T J ^a   Scherch, H M ^a   Lutzke, B S ^a   Sawada, G A ^a   Althaus, J S ^a   Vonvoigtlander, P F ^a   Padbury, G E ^a   Larson, P G ^a   Palmer, J R ^a   Bundy, G L ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; PYRROLOPYRIMIDINE DERIVATIVE; TIRILAZAD; U 101033; U 104067; U 106311; U 87663; U 89843; U 94430; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG UPTAKE; FEMALE; FETUS; GERBIL; HIPPOCAMPUS; INTRAVENOUS DRUG ADMINISTRATION; LIPID PEROXIDATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; BRAIN; BRAIN INJURIES; BRAIN ISCHEMIA; FEMALE; FREE RADICAL SCAVENGERS; GERBILLINAE; LIPID PEROXIDATION; MALE; MICE; NEUROPROTECTIVE AGENTS; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 8244227987     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. AUDUS, K. L., GUILLOT, F. L. AND BRAUGHLER, J. M.: Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells. Free Radic. Biol. Med. 11: 361-371, 1991.
2. BECK, T. AND BIELENBERG, G. W.: Failure of the lipid peroxidation inhibitor U-74006F to improve neurologic outcome after transient forebrain ischemia in the rat. Brain Res. 532: 336-338, 1990.
3. BECK, T. AND BIELENBERG, G. W.: The effects of two 21-aminosteroids on overt infarct size 48 hours after middle cerebral artery occlusion in the rat. Brain Res. 560: 159-162, 1991.
4. BRAUGHLER, J. M. AND HALL, E. D.: Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic. Biol. Med. 6: 289-301, 1989.
5. BUCHAN, A. M., BRUEDERLIN, B., HEINICKE, E. AND LI, H.: Failure of the lipid peroxidation inhibitor U-74006F to prevent postischemic selective neuronal injury. J. Cereb. Blood Flow Metab. 12: 250-256, 1992.
6. BUNDY, G. L., AYER, D. E., BANITT, L. S., BELONGA, K. L., MIZSAK, S. A., PALMER, J. R., TUSTIN, J. M., CHIN, J. E., HALL, E. D., LINSEMAN, K. L., RICHARDS, I. M., SCHERCH, H. M., SUN, F. F., YONKERS, P. A., LARSEN, P. G., LIN, J. M., PADBURY, G. E., AARON, C. S. AND MAYO, J. K.: Synthesis of novel 2,4-diaminopyrrolo[2,3-d]pyrimidines with antioxidant, neuroprotective and antiasthma activity. J. Med. Chem. 38: 4161-4163, 1995.
7. BUXSER, S., BONVENTRE, P. F.: Staphylococcal enterotoxins fail to disrupt membrane integrity or synthetic functions of Henle 407 intestinal cells. Infect. Immun. 31: 929-934, 1981.
8. CAO, X. AND PHILLIS, J. W.: α-Phenyl-tert-butyl nitrone reduces cortical infarct and edema in rats subjected to focal ischemia. Brain Res. 644: 267-272, 1994.
9. CLEMENS, J. A., HO, P. P. K. AND PANETTA, J. A.: LY178002 reduces rat brain damage after transient global forebrain ischemia. Stroke 22: 1048-1052, 1991.
10. COHEN, G.: Monoamine oxidase, hydrogen peroxide and Parkinson's disease. Adv. Neurol. 45: 119-125, 1986.
11. FICI, G. J., ALTHAUS, J. S. AND VONVOIGTLANDER, P. F.: Effects of lazaroids and a peroxynitrite scavenger in a cell model of peroxynitrite toxicity. Free Radic. Biol. Med. 22: 223-228, 1996.
12. GURNEY, M. E., CUTTING, F. B., ZHAI, P., DOBLE, A., TAYLOR, C. P., ANDRUS, P. K. AND HALL, E. D.: Antioxidants and inhibitors of glutamatergic transmission have therapeutic benefit in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39: 147-157, 1996.
13. HALL, E. D., ANDRUS, P. K., COX, J. W. AND ANDERSON, D. K.: Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury. J. Neurotrauma 9: suppl. 2, S425-S442, 1992.
14. HALL, E. D., ANDRUS, P. K., SMITH, S. L., OOSTVEEN, J. A., SCHERCH, H. M., LUTZKE, B. S., RAUB, T. J., SAWADA, G. A., PALMER, J. R., BANITT, L. S., TUSTIN, J. M., BELONGA, K. L., AYER, D. E. AND BUNDY, G. L.: Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants. Acta Neurochir. 66: suppl., 107-113, 1995.
15. HALL, E. D., ANDRUS, P. K. AND PAZARA, K. E.: Protective efficacy of a hypothermic pharmacological agent in gerbil forebrain ischemia. Stroke 24: 711-715, 1993.
16. HALL, E. D. AND BRAUGHLER, J. M.: Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6: 303-313, 1989.
17. HALL, E. D., BRAUGHLER, J. M., YONKERS, P. A., SMITH, S. L., LINSEMAN, K. L., MEANS, E. D., SCHERCH, H. M., JACOBSEN, E. J. AND LAHTI, R. A.: U78517F: a potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia. J. Pharmacol. Exp. Ther. 258: 688-694, 1991.
18. HALL, E. D., MCCALL, J. M. AND MEANS, E. D.: Therapeutic potential of the lazaroids (21-aminosteroids) in central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol. 28: 221-268, 1994.
19. HALL, E. D. AND PAZARA, K. E.: A quantitative analysis of the effects of kappa opioid agonists on post-ischemic hippocampal CA1 neuronal necrosis in gerbils. Stroke 19: 1008-1012, 1988.
20. HALL, E. D., YONKEKS, P. A., MCCALL, J. M. AND BRAUGHLER, J. M.: Effects of the 21-aminosteroid U-74006F on experimental head injury in mice. J. Neurosurg. 68: 456-461, 1988.
21. JENNER, P., SCHAPIRA, A. H. V. AND MARSDEN, C. D.: New insights into the cause of Parkinson's disease. Neurology 42: 2241-2250, 1992.
22. KASSELL, N. F., HALEY, E. C., APPERSON-HANSEN, C. AND ALVES, W. M.: A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage. J. Neurosurg. 84: 221-228, 1996.
23. PAHLMARK, K., FOLBERGROVA, J., SMITH, M.-L. AND SIESJO, B. K.: Effects of dimethylthiourea on selective neuronal vulnerability in forebrain ischemia in rats. Stroke 24: 731-737, 1993.
24. PARK, C. K. AND HALL, E. D.: Dose-response analysis of the 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia. Brain Res. 645: 157-163, 1994.
25. PHILLIS, J. W. AND CLOUGH-HELFMAN, C.: Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-α-phenylnitrone (PBN). Neurosci. Lett. 116: 315-319, 1990.
26. PREHN, J. H. M., KARKOUTLY, C., NUGLISCH, J., PERUCHE, B. AND KRIEGLSTEIN, J.: Dihydrolipoate reduces neuronal injury after cerebral ischemia. J. Cereb. Blood Flow Metab. 12: 78-87, 1992.
27. RAUB, T. J., BARSUHN, C. L., WILLIAMS, L. R., DECKER, D. E., SAWADA, G. A. AND HO, N. F. H.: Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers. J. Drug Target. 1: 269-286, 1993.
28. ROSEN, D. R., SIDDIQUE, T., PATTERSON, D., FIGLEWICZ, D. A., SAPP, P., HENTATI, A., DONALDSON, D., GOTO, J., O'REGAN, J. P., DENG, H.-X., RAHMANI, Z., KRIZUS, A., MCKENNA-YASEK, D., CAYABYAB, A., GASTON, S. M., BERGER, R., TANZI, R. E., HALPERIN, J. J., HERZFELDT, B., VAN DEN BERGH, R., HUNG, W.-Y., BIRD, R., DENG, G., MULDER, D. W., SMYTH, C., LAING, N. G., SORIANO, E., PERICAK-VANCE, M. A., HAINES, J., ROULEAU, G. A., GUSELLA, J. S., HORVITZ, H. R. AND BROWN, R. H.: Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59-62, 1993.
29. SAWADA, G. A., HO, N. F. H., BARSUHN, C. L., HOUGHTON, M. E., LUTZKE, B. S., PADBURY, G. E. AND RAUB, T. J.: Increased lipophilicity and cell partitioning decreases passive transcellular diffusion of a novel class of highly lipophilic antioxidants. Pharm. Res. 12: suppl., S-311, 1995a.
30. SAWADA, G. A., WILLIAMS, L. R. AND RAUB, T. J.: A novel class of membrane-interactive antioxidants readily cross the blood-brain barrier and penetrate into cells. Pharm. Res. 12: suppl., S-300, 1995b.
31. SCHMID-ELSAESSER, R., ZAUSINGER, S., BAETHMANN, A. AND REULEN, H.-J.: Superior effect of the brain-penetrating (U-101033E) versus endothelium-attached antioxidant (U-74389G) on infarct size and neurological outcome after focal reversible ischemia. Cerebrovasc. Dis. 6(suppl 2): 43, 1996.
32. SIESJO, B. K., AGARDH, C.-D. AND BENGTSSON, F.: Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev. 1: 165-211, 1989.
33. SMITH, M. A., RICHEY, P. L., TANEDA, S., KUTTY, R. K., SAYRE, L. M., MONNIER, V. M. AND PERRY, G.: Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann. NY Acad. Sci. 738: 447-454, 1994.
34. SUBBARAO, K. V., RICHARDSON, J. S. AND ANG, L. C.: Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55: 342-345, 1990.
35. SUTHERLAND, G., HAAS, N. AND PEELING, J.: Ischemic neocortical protection with U74006F: A dose-response curve. Neurosci. Lett. 149: 123-125, 1993.
36. XUE, D., SLIVKA, A. AND BUCHAN, A. M.: Tirilazad reduces cortical infarction after transient, but not permanent focal cerebral ischemia in rats. Stroke 23: 894-899, 1992.
37. YOUDIM, M. B. H., BEN-SCHACHAR, D. AND RIEDERER, P.: The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8: 1-12, 1993.
38. ZHANG, J.-R., SCHERCH, H. M. AND HALL, E. D.: Direct measurement of lipid hydroperoxides in iron-dependent spinal neuronal injury. J. Neurochem. 66: 355-361, 1996.
39. ZHAO, Q., PAHLMARK, K., SMITH, M.-L. AND SIESJO, B. K.: Delayed treatment with the spin trap α-phenyl-N-tert-butyl nitrone. Acta Physiol. Scand. 152: 349-350, 1994.